Candida auris: A Latent Threat to Critically Ill Patients With Coronavirus Disease 2019.
作者信息
Rodriguez Jose Y, Le Pape Patrice, Lopez Olga, Esquea Kelin, Labiosa Anny L, Alvarez-Moreno Carlos
机构信息
Centro de Investigaciones Microbiológicas del Cesar, Valledupar, Colombia.
Clínica alta complejidad Valledupar, Cesar, Colombia.
出版信息
Clin Infect Dis. 2021 Nov 2;73(9):e2836-e2837. doi: 10.1093/cid/ciaa1595.
Abstract
摘要
相似文献
1
Candida auris: A Latent Threat to Critically Ill Patients With Coronavirus Disease 2019.
Clin Infect Dis. 2021 Nov 2;73(9):e2836-e2837. doi: 10.1093/cid/ciaa1595.
2
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020.
Emerg Infect Dis. 2020 Nov;26(11):2694-2696. doi: 10.3201/eid2611.203504. Epub 2020 Aug 27.
3
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic.
J Glob Antimicrob Resist. 2020 Sep;22:175-176. doi: 10.1016/j.jgar.2020.06.003. Epub 2020 Jun 12.
4
Invasive Infections during a COVID-19 Case Surge.
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0114621. doi: 10.1128/AAC.01146-21. Epub 2021 Aug 2.
5
Candida auris in critically ill patients: Emerging threat in intensive care unit of hospitals.
J Mycol Med. 2018 Sep;28(3):514-518. doi: 10.1016/j.mycmed.2018.06.005. Epub 2018 Jul 2.
6
Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind.
Dermatol Ther. 2020 Jul;33(4):e13481. doi: 10.1111/dth.13481. Epub 2020 May 27.
7
Nanopore Genome Sequencing and Variant Analysis of the Susceptible Candida auris Strain L1537/2020, Salvador, Brazil.
Mycopathologia. 2021 Dec;186(6):883-887. doi: 10.1007/s11046-021-00593-7. Epub 2021 Oct 20.
8
Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.
Clin Infect Dis. 2005 Dec 1;41(11):1690-1. doi: 10.1086/498349.
9
Candida auris: An Emerging Antimicrobial Resistance Threat.
Ann Intern Med. 2019 Sep 17;171(6):432-433. doi: 10.7326/M19-2205. Epub 2019 Jul 30.
10
Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review.
Int J Antimicrob Agents. 2012 Jan;39(1):1-10. doi: 10.1016/j.ijantimicag.2011.07.013. Epub 2011 Sep 16.
引用本文的文献
1
Impact of on Critically Ill Patients: A Three-Year Observational Study in a Greek Intensive Care Unit.
Pathogens. 2025 Mar 28;14(4):328. doi: 10.3390/pathogens14040328.
2
Candidemia Following Severe COVID-19 in Hospitalised and Critical Ill Patients: A Systematic Review and Meta-Analysis.
Mycoses. 2024 Oct;67(10):e13798. doi: 10.1111/myc.13798.
3
Evaluation of Blood Cultures from SARS-CoV-2-Positive and Negative Adult Patients.
Healthcare (Basel). 2023 Sep 19;11(18):2581. doi: 10.3390/healthcare11182581.
4
Nanotechnology-Based Strategies to Combat Multidrug-Resistant Infections.
Pathogens. 2023 Aug 13;12(8):1033. doi: 10.3390/pathogens12081033.
5
Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022.
Emerg Infect Dis. 2023 Jul;29(7):1297-1301. doi: 10.3201/eid2907.221888.
6
: outbreak fungal pathogen in COVID-19 pandemic: a systematic review and meta-analysis.
Iran J Microbiol. 2022 Jun;14(3):276-284. doi: 10.18502/ijm.v14i3.9753.
7
Assessing and Reassessing the Association of Comorbidities and Coinfections in COVID-19 Patients.
Cureus. 2023 Mar 25;15(3):e36683. doi: 10.7759/cureus.36683. eCollection 2023 Mar.
8
The Mortality Attributable to Candidemia in Is Higher than That in Other Species: Myth or Reality?
J Fungi (Basel). 2023 Mar 31;9(4):430. doi: 10.3390/jof9040430.
9
Perspective on the origin, resistance, and spread of the emerging human fungal pathogen Candida auris.
PLoS Pathog. 2023 Mar 23;19(3):e1011190. doi: 10.1371/journal.ppat.1011190. eCollection 2023 Mar.
10
Worsening Spread of in the United States, 2019 to 2021.
Ann Intern Med. 2023 Apr;176(4):489-495. doi: 10.7326/M22-3469. Epub 2023 Mar 21.
Zotero 插件